Home › Cancer (all types) › Texas
Cancer (all types) clinical trials in Texas
185 studies for Cancer (all types) are looking for participants at sites in Texas.
Cities in Texas
- Houston124 studies
- San Antonio41 studies
- Dallas40 studies
- Austin22 studies
- Irving14 studies
- Fort Worth10 studies
- Tyler7 studies
- League City5 studies
- Killeen5 studies
- The Woodlands4 studies
- El Paso3 studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Oncology Consultants PA, Houston
- University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 13, 2026 · NCT05920356Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07672769A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- NEXT Oncology ( Site 1010), Austin
- NEXT Oncology ( Site 1011), Houston
- NEXT Oncology ( Site 1012), Irving
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06818643A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07197554A Study of YL242 in Subjects With Advanced Solid Tumors
- US-203, Houston
- US-207, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07197827Childhood Cancer Predisposition Study (CCPS)
- Baylor College of Medicine, Houston
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT04511806A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Texas Oncology - Central/South Texas /ID# 268563, Austin
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
- Oncology Consultants /ID# 268323, Houston
- and 1 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Dell Medical School, University of Texas at Austin, Austin
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- and 7 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
- Houston Methodist, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT07195591A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas at Tyler, Tyler
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 6, 2026 · NCT06983743Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
- The University of Texas Health Science Center at Tyler, Tyler
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT04198766Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases
- The Cancer Therapy and Research Center at UTHSCSA, San Antonio
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07098806Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
- University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT05852717A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
- NEXT Texas LLC - Austin, Austin
- NEXT Texas LLC - Dallas, Dallas
- START Dallas Fort Worth, LLC, Fort Worth
- and 4 more
RecruitingPhase 1
Ages 18 to 99 · All sexes · Updated Nov 5, 2026 · NCT07540572A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
- The Center For Cancer And Blood Disorders (Texas Cancer Care), Fort Worth
- Houston Methodist Cancer Center, Houston
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT06901531A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
- World Research Link, Baytown
- John Peter Smith Hospital, Fort Worth
- Kelsey-Seybold Clinic, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07169851A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06150157A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- USO - Texas Oncology, Austin
- William Beaumont Army Medical Center, Fort Bliss
- Houston Methodist Hospital, Houston
- and 3 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06119581Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
- University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT05856981A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06311578A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- MD Anderson Cancer Center, Houston
- NEXT Dallas, Irving
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07578571A Study of JNJ-1761981 in Participants With Solid Tumors
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT07525141TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors
- The University of Texas M. D. Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 3, 2026 · NCT06801041Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
- and 3 more
RecruitingPhase 2/3
All ages · All sexes · Updated Nov 2, 2026 · NCT03435796A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC
- University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06010329Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
- University of Texas MD Anderson Cancer Center, Houston
- NEXT Dallas, Irving
- NEXT San Antonio, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT06959706A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- NEXT Oncology ( Site 0051), Irving
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT07247110A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)
- University of Texas M.D. Anderson Cancer Center ( Site 4007), Houston
RecruitingPhase 1/2
1 Month – 17 Years · All sexes · Updated Oct 30, 2026 · NCT07630974PAS-004 in Patients With Advanced Solid Tumors
- NEXT Oncology, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 30, 2026 · NCT06299839Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- The University of Texas MD Anderson Cancer Center, Houston
RecruitingPhase 3
Ages 18 to 71 · All sexes · Updated Oct 30, 2026 · NCT07504458Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
- University of Texas Southwestern Medical Center, Dallas
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06601296A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
- NEXT Oncology Dallas, Irving
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT07094204Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
- Texas Oncology, Austin
- Texas Oncology - Northeast Texas, Tyler
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07566156Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- MD Anderson Cancer Center, Houston
RecruitingPhase 1
Ages 18 and older · Men · Updated Oct 27, 2026 · NCT05997615A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06953960A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
- Texas Oncology Dallas, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- Texas Oncology Lewisville Castle Hills, Lewisville
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 27, 2026 · NCT06010342Phase 2 Trial of Obinutuzumab and CC-99282 for Patients With Previously Untreated High Tumor Burden Follicular Lymphoma
- M D Anderson Cancer Center, Houston
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06108232A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Research Site, Houston
- Research Site #2, San Antonio
- Research Site, San Antonio
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06835569Connect for Cancer Prevention Study (Connect)
- Baylor Scott and White Health, Dallas
RecruitingObservational studyHealthy volunteers welcome
Ages 30 to 70 · All sexes · Updated Oct 26, 2026 · NCT04609072From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.